Page last updated: 2024-09-05

pectolinarin and camostat

pectolinarin has been researched along with camostat in 1 studies

Compound Research Comparison

Studies
(pectolinarin)
Trials
(pectolinarin)
Recent Studies (post-2010)
(pectolinarin)
Studies
(camostat)
Trials
(camostat)
Recent Studies (post-2010) (camostat)
260153371493

Protein Interaction Comparison

ProteinTaxonomypectolinarin (IC50)camostat (IC50)
Transmembrane protease serine 2Homo sapiens (human)0.018
ProthrombinHomo sapiens (human)0.399
Serine protease hepsinHomo sapiens (human)0.0235
Trypsin-1Homo sapiens (human)0.0035
Trypsin-2Homo sapiens (human)0.0035
Procathepsin LHomo sapiens (human)0.018
FurinHomo sapiens (human)0.018
Trypsin-3Homo sapiens (human)0.0035
Transmembrane protease serine 6Homo sapiens (human)0.018
Multidrug and toxin extrusion protein 1Homo sapiens (human)2.9

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X1

Reviews

1 review(s) available for pectolinarin and camostat

ArticleYear
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Journal of medicinal chemistry, 2020, 11-25, Volume: 63, Issue:22

    Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries

2020